Novo Nordisk stock jumps 6% after drugmaker hikes forcast as Wegovy pill sales smash forecasts

Novo Nordisk stock jumps 6% after drugmaker hikes forcast as Wegovy pill sales smash forecasts

Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill.